These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31418687)

  • 41. The in vitro fitness cost of antimicrobial resistance in Escherichia coli varies with the growth conditions.
    Petersen A; Aarestrup FM; Olsen JE
    FEMS Microbiol Lett; 2009 Oct; 299(1):53-9. PubMed ID: 19694815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genomics of rapid adaptation to antibiotics: convergent evolution and scalable sequence amplification.
    Laehnemann D; Peña-Miller R; Rosenstiel P; Beardmore R; Jansen G; Schulenburg H
    Genome Biol Evol; 2014 May; 6(6):1287-301. PubMed ID: 24850796
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microbiology. Antibiotic resistance, not shaken or stirred.
    Frisch RL; Rosenberg SM
    Science; 2011 Sep; 333(6050):1713-4. PubMed ID: 21940884
    [No Abstract]   [Full Text] [Related]  

  • 44. Evaluation of Acquired Antibiotic Resistance in
    Tirumalai MR; Karouia F; Tran Q; Stepanov VG; Bruce RJ; Ott CM; Pierson DL; Fox GE
    mBio; 2019 Jan; 10(1):. PubMed ID: 30647159
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the evolution of resistance to multiple antibiotics enables prediction of the Escherichia coli phenotype-based fitness landscape.
    Iwasawa J; Maeda T; Shibai A; Kotani H; Kawada M; Furusawa C
    PLoS Biol; 2022 Dec; 20(12):e3001920. PubMed ID: 36512529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli.
    Huseby DL; Pietsch F; Brandis G; Garoff L; Tegehall A; Hughes D
    Mol Biol Evol; 2017 May; 34(5):1029-1039. PubMed ID: 28087782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic constraints on the evolution of antibiotic resistance.
    Zampieri M; Enke T; Chubukov V; Ricci V; Piddock L; Sauer U
    Mol Syst Biol; 2017 Mar; 13(3):917. PubMed ID: 28265005
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial drug resistance genes do not convey a secondary fitness advantage to calf-adapted Escherichia coli.
    Khachatryan AR; Hancock DD; Besser TE; Call DR
    Appl Environ Microbiol; 2006 Jan; 72(1):443-8. PubMed ID: 16391076
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adaptation and compensation in a bacterial gene regulatory network evolving under antibiotic selection.
    Patel V; Matange N
    Elife; 2021 Sep; 10():. PubMed ID: 34591012
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Occurrence of the Colistin Resistance Gene
    Mikhayel M; Leclercq SO; Sarkis DK; Doublet B
    Microbiol Spectr; 2021 Oct; 9(2):e0002521. PubMed ID: 34494875
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adaptation Through Lifestyle Switching Sculpts the Fitness Landscape of Evolving Populations: Implications for the Selection of Drug-Resistant Bacteria at Low Drug Pressures.
    Matange N; Hegde S; Bodkhe S
    Genetics; 2019 Mar; 211(3):1029-1044. PubMed ID: 30670539
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Patterns of Epistasis between beneficial mutations in an antibiotic resistance gene.
    Schenk MF; Szendro IG; Salverda ML; Krug J; de Visser JA
    Mol Biol Evol; 2013 Aug; 30(8):1779-87. PubMed ID: 23676768
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutational Activation of Antibiotic-Resistant Mechanisms in the Absence of Major Drug Efflux Systems of Escherichia coli.
    Cho H; Misra R
    J Bacteriol; 2021 Jun; 203(14):e0010921. PubMed ID: 33972351
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Highly Contingent Phenotypes of Lon Protease Deficiency in Escherichia coli upon Antibiotic Challenge.
    Matange N
    J Bacteriol; 2020 Jan; 202(3):. PubMed ID: 31740490
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Selection of a multidrug resistance plasmid by sublethal levels of antibiotics and heavy metals.
    Gullberg E; Albrecht LM; Karlsson C; Sandegren L; Andersson DI
    mBio; 2014 Oct; 5(5):e01918-14. PubMed ID: 25293762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pervasive Selection for Clinically Relevant Resistance and Media Adaptive Mutations at Very Low Antibiotic Concentrations.
    Pereira C; Warsi OM; Andersson DI
    Mol Biol Evol; 2023 Jan; 40(1):. PubMed ID: 36627817
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The population genetics of collateral resistance and sensitivity.
    Ardell SM; Kryazhimskiy S
    Elife; 2021 Dec; 10():. PubMed ID: 34889185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence.
    Van den Bergh B; Michiels JE; Wenseleers T; Windels EM; Boer PV; Kestemont D; De Meester L; Verstrepen KJ; Verstraeten N; Fauvart M; Michiels J
    Nat Microbiol; 2016 Mar; 1():16020. PubMed ID: 27572640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of the SOS response modifies spatiotemporal evolution, post-antibiotic effect, bacterial fitness and biofilm formation in quinolone-resistant Escherichia coli.
    Recacha E; Machuca J; Díaz-Díaz S; García-Duque A; Ramos-Guelfo M; Docobo-Pérez F; Blázquez J; Pascual A; Rodríguez-Martínez JM
    J Antimicrob Chemother; 2019 Jan; 74(1):66-73. PubMed ID: 30329046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.